Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments

M. Scorsetti,Filippo Alongi,Antonella Fogliata,S. Pentimalli,P. Navarria,F. Lobefalo,Carlos A. Garcia-Etienne,A. Clivio,Luca Cozzi,P. Mancosu,G. Nicolini,Eugenio Vanetti,M. Eboli,Carlo Rossetti,Arianna Rubino,Andrea Sagona,Stefano Arcangeli,Wolfgang Gatzemeier,Giovanna Masci,Rosalba Torrisi,Alberto Testori,Marco Alloisio,Armando Santoro,Corrado Tinterri

Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments

2012

Background To report results in terms of feasibility and early toxicity of hypofractionated simultaneous integrated boost (SIB) approach with Volumetric Modulated Arc Therapy (VMAT) as adjuvant treatment after breast-conserving surgery.

Keywords:

Radiology
Medical physics
Breast cancer
Arc (geometry)
Adjuvant
Toxicity
Neoplasm Grading
Radiation therapy
Dose fractionation
Medicine
Oncology
Internal medicine
simultaneous integrated boost
phase i ii
volumetric modulated arc therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations